Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2020 Filed Feb 21, 2020 01:18 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
Exercise / conversionCommon Stock | 5,000 | $2.96 | $14,800.00 |
DisclosureSEC source: 0001562180-20-001433 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 19,602 restricted stock units. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 19:58 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 6,500 | $27.17 | $176,614.10 |
DisclosureSEC source: 0001562180-20-001259 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,115,933 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.66 to $27.65. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 174,750 restricted stock units. Read SEC document |
| February 11, 2020 Filed Feb 11, 2020 21:50 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 1,667 | $27.88 | $46,475.96 |
DisclosureSEC source: 0001562180-20-001085 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,693 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2019. F2 · balance_after: Includes 8,721 restricted stock units. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 16:15 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 6,500 | $27.56 | $179,140.00 |
DisclosureSEC source: 0001562180-20-001011 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,122,433 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $27.14 to $28.12. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 174,750 restricted stock units. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:44 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-20-000945 · primarydocument.xml · derivative · entry 8 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,907 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:44 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 2,300 | $27.65 | $63,593.85 |
DisclosureSEC source: 0001562180-20-000945 · primarydocument.xml · nonDerivative · entry 6 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 192,766 F2 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F5 · price: This transaction was executed in multiple trades at prices ranging from $27.27 to $27.94. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:44 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,600 | $27.70 | $44,320.00 |
DisclosureSEC source: 0001562180-20-000945 · primarydocument.xml · nonDerivative · entry 5 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,602 F2 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F1 · balance_after: Includes 2,270 Restricted Stock Units. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:44 UTC |
Madaus Martin DDirector
|
Exercise / conversionCommon Stock | 1,600 | $1.93 | $3,088.00 |
DisclosureSEC source: 0001562180-20-000945 · primarydocument.xml · nonDerivative · entry 4 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,270 Restricted Stock Units. Read SEC document |
| February 04, 2020 Filed Feb 4, 2020 22:49 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
SaleCommon Stock | 55 | $26.71 | $1,469.05 |
DisclosureSEC source: 0001562180-20-000853 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,184 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 148 RSUs. F2 · balance_after: Includes 11,245 restricted stock units. Read SEC document |
| February 04, 2020 Filed Feb 4, 2020 22:47 UTC |
Mattoon DawnSr. VP, Research Products
|
SaleCommon Stock | 137 | $26.71 | $3,659.27 |
DisclosureSEC source: 0001562180-20-000852 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,104 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 368 RSUs. F2 · balance_after: Includes 16,552 restricted stock units. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 16:28 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 2,409 | $26.71 | $64,344.39 |
DisclosureSEC source: 0001562180-20-000894 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,128,933 F3 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 7,123 RSUs. F4 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 174,750 restricted stock units. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:44 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-20-000945 · primarydocument.xml · derivative · entry 7 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,507 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:44 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 2,300 | $26.95 | $61,987.99 |
DisclosureSEC source: 0001562180-20-000945 · primarydocument.xml · nonDerivative · entry 3 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 195,066 F2 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $26.47 to $27.425. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:44 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,600 | $26.52 | $42,432.00 |
DisclosureSEC source: 0001562180-20-000945 · primarydocument.xml · nonDerivative · entry 2 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,602 F2 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F1 · balance_after: Includes 2,270 Restricted Stock Units. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:44 UTC |
Madaus Martin DDirector
|
Exercise / conversionCommon Stock | 1,600 | $1.93 | $3,088.00 |
DisclosureSEC source: 0001562180-20-000945 · primarydocument.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,270 Restricted Stock Units. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 16:28 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 600 | $27.48 | $16,488.00 |
DisclosureSEC source: 0001562180-20-000894 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131,342 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 16:28 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 5,900 | $27.05 | $159,569.04 |
DisclosureSEC source: 0001562180-20-000894 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131,942 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.44 to $27.40. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 29, 2020 Filed Jan 29, 2020 19:54 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 6,500 | $26.99 | $175,407.05 |
DisclosureSEC source: 0001562180-20-000682 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,137,842 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.70 to $27.31. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 181,873 restricted stock units. Read SEC document |
| January 23, 2020 Filed Jan 24, 2020 21:34 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-20-000557 · primarydocument.xml · derivative · entry 8 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,107 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
| January 23, 2020 Filed Jan 24, 2020 21:34 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 2,300 | $25.60 | $58,874.94 |
DisclosureSEC source: 0001562180-20-000557 · primarydocument.xml · nonDerivative · entry 6 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 197,366 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $25.400 to $25.780. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| January 23, 2020 Filed Jan 24, 2020 21:34 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,600 | $24.86 | $39,776.00 |
DisclosureSEC source: 0001562180-20-000557 · primarydocument.xml · nonDerivative · entry 5 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,602 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. Read SEC document |
| January 23, 2020 Filed Jan 24, 2020 21:34 UTC |
Madaus Martin DDirector
|
Exercise / conversionCommon Stock | 1,600 | $1.93 | $3,088.00 |
DisclosureSEC source: 0001562180-20-000557 · primarydocument.xml · nonDerivative · entry 4 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:34 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-20-000557 · primarydocument.xml · derivative · entry 7 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,707 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:34 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 2,300 | $25.43 | $58,484.40 |
DisclosureSEC source: 0001562180-20-000557 · primarydocument.xml · nonDerivative · entry 3 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 199,666 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $24.995 to $25.850. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:34 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,600 | $25.15 | $40,240.00 |
DisclosureSEC source: 0001562180-20-000557 · primarydocument.xml · nonDerivative · entry 2 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,602 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:34 UTC |
Madaus Martin DDirector
|
Exercise / conversionCommon Stock | 1,600 | $1.93 | $3,088.00 |
DisclosureSEC source: 0001562180-20-000557 · primarydocument.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 17:12 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 6,500 | $24.07 | $156,443.95 |
DisclosureSEC source: 0001562180-20-000481 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,144,342 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $23.93 to $24.20. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 181,873 restricted stock units. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 22:12 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001562180-20-000480 · primarydocument.xml · derivative · entry 3 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,455 Underlying: Common Stock · 5,000 shares Expires 2024-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option is fully vested. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 22:12 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
SaleCommon Stock | 5,000 | $24.04 | $120,182.00 |
DisclosureSEC source: 0001562180-20-000480 · primarydocument.xml · nonDerivative · entry 2 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,239 F2 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $23.71 to $24.19. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 11,393 restricted stock units. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 22:12 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
Exercise / conversionCommon Stock | 5,000 | $2.96 | $14,800.00 |
DisclosureSEC source: 0001562180-20-000480 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 11,393 restricted stock units. Read SEC document |
| January 17, 2020 Filed Jan 17, 2020 20:40 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 6,500 | $24.41 | $158,665.00 |
DisclosureSEC source: 0001562180-20-000433 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150,842 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 181,873 restricted stock units. Read SEC document |
| January 17, 2020 Filed Jan 18, 2020 01:46 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionStock Option (Right to buy) · Derivative | 1,941 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-20-000434 · primarydocument.xml · derivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,941 shares Expires 2021-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option is fully vested. Read SEC document |
| January 17, 2020 Filed Jan 18, 2020 01:46 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 1,941 | $23.99 | $46,564.59 |
DisclosureSEC source: 0001562180-20-000434 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,360 F2 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $23.95 to $24.03. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 8,835 restricted stock units. Read SEC document |
| January 17, 2020 Filed Jan 18, 2020 01:46 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionCommon Stock | 1,941 | $1.93 | $3,746.13 |
DisclosureSEC source: 0001562180-20-000434 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 8,835 restricted stock units. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 20:40 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 6,500 | $22.17 | $144,129.70 |
DisclosureSEC source: 0001562180-20-000433 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,157,342 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.05 to $22.25. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 181,873 restricted stock units. Read SEC document |
| January 09, 2020 Filed Jan 9, 2020 22:53 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-20-000313 · primarydocument.xml · derivative · entry 8 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,307 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
| January 09, 2020 Filed Jan 9, 2020 22:53 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 2,300 | $21.94 | $50,461.54 |
DisclosureSEC source: 0001562180-20-000313 · primarydocument.xml · nonDerivative · entry 6 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 201,966 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F5 · price: This transaction was executed in multiple trades at prices ranging from $21.61 to $22.095. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| January 09, 2020 Filed Jan 9, 2020 22:53 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,600 | $22.33 | $35,728.00 |
DisclosureSEC source: 0001562180-20-000313 · primarydocument.xml · nonDerivative · entry 5 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,602 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. Read SEC document |
| January 09, 2020 Filed Jan 9, 2020 22:53 UTC |
Madaus Martin DDirector
|
Exercise / conversionCommon Stock | 1,600 | $1.93 | $3,088.00 |
DisclosureSEC source: 0001562180-20-000313 · primarydocument.xml · nonDerivative · entry 4 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2020 Filed Jan 9, 2020 22:53 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-20-000313 · primarydocument.xml · derivative · entry 7 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,907 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
| January 08, 2020 Filed Jan 9, 2020 22:53 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 2,300 | $22.78 | $52,382.73 |
DisclosureSEC source: 0001562180-20-000313 · primarydocument.xml · nonDerivative · entry 3 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 204,266 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $22.38 to $23.09. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| January 08, 2020 Filed Jan 9, 2020 22:53 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,600 | $23.15 | $37,041.92 |
DisclosureSEC source: 0001562180-20-000313 · primarydocument.xml · nonDerivative · entry 2 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,602 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $23.11 to $23.18. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 08, 2020 Filed Jan 9, 2020 22:53 UTC |
Madaus Martin DDirector
|
Exercise / conversionCommon Stock | 1,600 | $1.93 | $3,088.00 |
DisclosureSEC source: 0001562180-20-000313 · primarydocument.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:04 UTC |
MEISTER PAUL MDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $23.12 | $0.00 |
DisclosureSEC source: 0001562180-20-000209 · primarydocument.xml · derivative · entry 3 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2030-01-02 F5 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:04 UTC |
MEISTER PAUL MDirector
|
GrantCommon Stock | 594 | $23.12 | $13,733.28 |
DisclosureSEC source: 0001562180-20-000209 · primarydocument.xml · nonDerivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,021 F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2019. F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 2, 2020. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:04 UTC |
MEISTER PAUL MDirector
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-000209 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,427 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2020 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:04 UTC |
Connolly John MDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $23.12 | $0.00 |
DisclosureSEC source: 0001562180-20-000204 · primarydocument.xml · derivative · entry 2 Connolly John M · CIK 0001482893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2030-01-02 F3 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:04 UTC |
Connolly John MDirector
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-000204 · primarydocument.xml · nonDerivative · entry 1 Connolly John M · CIK 0001482893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,510 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2020 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:04 UTC |
Hlavinka Sarah E.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $23.12 | $0.00 |
DisclosureSEC source: 0001562180-20-000207 · primarydocument.xml · derivative · entry 3 Hlavinka Sarah E. · CIK 0001433554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2030-01-02 F5 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:04 UTC |
Hlavinka Sarah E.Director
|
GrantCommon Stock | 432 | $23.12 | $9,987.84 |
DisclosureSEC source: 0001562180-20-000207 · primarydocument.xml · nonDerivative · entry 2 Hlavinka Sarah E. · CIK 0001433554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,562 F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2019. F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 2, 2020. F2 · balance_after: Includes 6,810 restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.